OXiGENE, Inc. News Headlines

OXGN 
$1.87
*  
0.05
2.75%
Get OXGN Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading OXGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Which Chemotherapy Should OXiGENE Test Their Zybrestat+Avastin Combo Against?
11/17/2014 11:42:00 AM - Seeking Alpha


OXiGENE: Q3 Earnings And Avastin Approval, Bull Thesis Reiterated
11/14/2014 4:20:00 PM - Seeking Alpha


Oxigene: Why I Think This Risky Biotech Is A Speculative Buy
11/14/2014 9:15:00 AM - Seeking Alpha


Earnings After The Bell - Nov 12
11/13/2014 6:45:00 AM - RTT News


Oxigene Q3 14 Earnings Conference Call At 4:30 PM ET
11/12/2014 3:00:00 PM - RTT News


Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
11/12/2014 5:12:00 AM - TheStreet


Update: OXiGENE Presents Zybrestat/Avastin Data, Bull Thesis Remains Intact
11/11/2014 5:56:00 AM - Seeking Alpha


Lower Your Expectations For OXiGENE's Presentation At The November 8 International Gynecologic Cancer Society Meeting
11/6/2014 10:15:00 AM - Seeking Alpha


BCLI Gets A Pat On The Back, OXGN At Work, MDGN Rises After Hours
10/8/2014 12:51:00 AM - RTT News


Update: OXiGENE Initiates Clinical Trial -- Shares Rise
9/18/2014 7:35:00 AM - Seeking Alpha


Rosetta Blooms, FLXN Knocked Down, RNA In Demand, Concert Strikes Sweet Note
9/17/2014 11:58:00 PM - RTT News


Update: OXiGENE Earnings - Q2 Miss Challenges My Patience
8/6/2014 12:48:00 PM - Seeking Alpha


Update: CEO Departure And Recent Capital Raise At OXiGENE Reaffirms Bull Thesis
7/28/2014 3:00:00 PM - Seeking Alpha


Pitt Hyde & Mason Hawkins Buy >50% Stake In GTx Ahead Of Phase II Results
4/29/2014 8:40:00 AM - Seeking Alpha


8 Biotech Events To Anticipate This Year: Part One
4/7/2014 4:46:00 PM - Seeking Alpha


OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals
3/25/2014 1:35:00 PM - Seeking Alpha


Earnings Reaction History: OXiGENE, Inc., 33.3% Follow-Through Indicator, 6.6% Sensitive
3/18/2014 5:24:43 AM - MT Newswires


Healthcare Stocks Still Sliding Near Bell; Oxigene Rises Over 5% After $5.8-Mln Private Placement
9/19/2013 2:49:26 PM - MT Newswires


Sector Update: Healthcare
9/19/2013 2:47:56 PM - MT Newswires


Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low
9/3/2013 10:34:28 AM - GuruFocus


OXiGENE's Oncology Drugs Have Run Their Course
5/1/2013 10:33:00 AM - Seeking Alpha


Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
3/24/2013 4:30:00 AM - Seeking Alpha


Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developments
11/23/2012 12:55:00 PM - Seeking Alpha


Will the Next Apple or Google Be Found Among These Micro Caps?
8/18/2011 9:17:00 AM - Seeking Alpha


7 Big Movers That Investors Must Watch This Week
6/6/2011 8:52:00 AM - Seeking Alpha